The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Chronic Fatigue Therapy
Epinephrine, Gold, Chelidonium Majus, Echinacea, Ginkgo, Helleborus Niger, Phosphoric Acid, Scutellaria Lateriflora, Thuja Occidentalis · SCUTELLARIA LATERIFLORA 6 [hp_X]/1; THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/1; GINKGO 3 [hp_X]/1; CHELIDONIUM MAJUS 6 [hp_X]/1; EPINEPHRINE 7 [hp_X]/1; PHOSPHORIC ACID 6 [hp_X]/1; ECHINACEA, UNSPECIFIED 3 [hp_X]/1; GOLD 8 [hp_X]/1; HELLEBORUS NIGER ROOT 6 [hp_X]/1 · Tablet, Orally Disintegrating · Oral · TRP Company
NDC 17312-0170-14 · 1 BOTTLE in 1 PACKAGE / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Epinephrine, Gold, Chelidonium Majus, Echinacea, Ginkgo, Helleborus Niger, Phosphoric Acid, Scutellaria Lateriflora, Thuja Occidentalis (Tablet, Orally Disintegrating)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| TRP Company | SCUTELLARIA LATERIFLORA 6 [hp_X]/1; THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/1; GINKGO 3 [hp_X]/1; CHELIDONIUM MAJUS 6 [hp_X]/1; EPINEPHRINE 7 [hp_X]/1; PHOSPHORIC ACID 6 [hp_X]/1; ECHINACEA, UNSPECIFIED 3 [hp_X]/1; GOLD 8 [hp_X]/1; HELLEBORUS NIGER ROOT 6 [hp_X]/1 | Aug 26, 2026 | Sep 2, 2026 |
| TRP Company | SCUTELLARIA LATERIFLORA 6 [hp_X]/1; THUJA OCCIDENTALIS LEAFY TWIG 3 [hp_X]/1; GINKGO 7 [hp_X]/1; CHELIDONIUM MAJUS 3 [hp_X]/1; EPINEPHRINE 8 [hp_X]/1; PHOSPHORIC ACID 6 [hp_X]/1; ECHINACEA, UNSPECIFIED 6 [hp_X]/1; GOLD 6 [hp_X]/1; HELLEBORUS NIGER ROOT 6 [hp_X]/1 | Jul 22, 2026 | Aug 19, 2026 |
| TRP Company | CHELIDONIUM MAJUS 6 [hp_X]/1; ECHINACEA, UNSPECIFIED 3 [hp_X]/1; EPINEPHRINE 7 [hp_X]/1; GINKGO 3 [hp_X]/1; GOLD 8 [hp_X]/1; HELLEBORUS NIGER ROOT 6 [hp_X]/1; PHOSPHORIC ACID 6 [hp_X]/1; SCUTELLARIA LATERIFLORA 6 [hp_X]/1; THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Chronic Fatigue Therapy — NDC 17312-0170-14," retrieved September 3, 2026, https://drugdashboards.com/drug/17312017014.
Free to cite with attribution — see how the data is put together.